Chronic Treatment With 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Increases Insulin-Stimulated Glucose Uptake and GLUT4 Translocation in Rat Skeletal Muscles in a Fiber Type—Specific Manner
Chronic Treatment With 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Increases Insulin-Stimulated Glucose Uptake and GLUT4 Translocation in Rat Skeletal Muscles in a Fiber Type—Specific Manner Esben S. Buhl , Niels Jessen , Ole Schmitz , Steen B. Pedersen , Oluf Pedersen , Geoffrey D. Holman a...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2001-01, Vol.50 (1), p.12-17 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Chronic Treatment With
5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Increases
Insulin-Stimulated Glucose Uptake and GLUT4 Translocation in Rat Skeletal
Muscles in a Fiber Type—Specific Manner
Esben S. Buhl ,
Niels Jessen ,
Ole Schmitz ,
Steen B. Pedersen ,
Oluf Pedersen ,
Geoffrey D. Holman and
Sten Lund
From the Medical Research Laboratory and Medical Department M
(Endocrinology and Diabetes) (E.S.B., N.J., O.S., S.L.), Aarhus
Kommune-hospital; the Department of Endocrinology and Internal Medicine
(S.B.P.), Aarhus Amtssygehus, Aarhus University Hospital; the Institute of
Clinical Pharmacology (O.S.), University of Aarhus, Aarhus; the Steno Diabetes
Centre and Hagedorn Research Institute (O.P.), Gentofte, Copenhagen, Denmark;
and the Department of Biology and Biochemistry (G.D.H.), University of Bath,
Claverton Down, U.K.
Address correspondence and reprint requests to Sten Lund, MD, Medical
Department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus
Kommunehospital, DK-8000 Aarhus C, Denmark. E-mail:
sl{at}dadlnet.dk
.
Abstract
Recent studies have demonstrated that chronic administration of AICAR
(5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside), an activator of
the AMP-activated protein kinase, increases hexokinase activity and the
contents of total GLUT4 and glycogen in rat skeletal muscles. To explore
whether AICAR also affects insulin-stimulated glucose transport and GLUT4 cell
surface content, Wistar rats were subcutaneously injected with AICAR for 5
days in succession (1 mg/g body wt). Maximally insulin-stimulated (60 nmol/l)
glucose uptake was markedly increased in epitrochlearis (EPI) muscle (average
63%, P < 0.001, n = 18-19) and in extensor digitorum
longus muscle (average 26%, P < 0.001, n = 26-30). In
contrast, administration of AICAR did not maximally influence
insulin-stimulated glucose transport in soleus muscle. Studies of EPI muscle
with the
4,4′- O -[2-[2-[2-[2-[2-[6-(biotinylamino)hexanoyl]amino]ethoxy]ethoxy]ethoxy]-4-(1-azi-2,2,2,-trifluoroethyl)benzoyl]amino-1,3-propanediyl]bis-D-mannose
photolabeling technique showed a concomitant increase (average 68%, P
< 0.02) in cell surface GLUT4 content after insulin exposure in
AICAR-injected rats when compared with controls. In conclusion, 5 days of
AICAR administration induces a pronounced fiber type-specific increase in
insulin-stimulated glucose uptake and GLUT4 cell surface content in rat
skeletal muscle with the greatest effect observed on white fast-twitch
g |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.50.1.12 |